NIGROSTRIATAL DAMAGE IS REQUIRED FOR INDUCTION OF DYSKINESIAS BY L-DOPA IN SQUIRREL-MONKEYS

被引:110
作者
BOYCE, S
RUPNIAK, NMJ
STEVENTON, MJ
IVERSEN, SD
机构
[1] Merck Sharp and Dohme, Research Laboratories, Neuroscience Research Centre, Harlow CM20 1QR, East Wick Road
关键词
dyskinesias; L-DOPA; Parkinson's disease; squirrel monkey;
D O I
10.1097/00002826-199010000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the ability of L-DOPA to induce dyskinesias in MPTP-treated and normal squirrel monkeys to establish whether the underlying neuropathology associated with parkinsonism is an absolute requirement or merely promotes the development of drug-induced dyskinesias. Administration of L-DOPA (5-40 mg/kg p.o., following a 60 min pretreatment with carbidopa 2.5-20 mg/kg p.o.) induced a range of dopamine-mediated behaviours including locomotor activity, stereotyped scratching, and climbing in both lesioned and nonlesioned animals. However, the dose-response curves showed a marked (three- to fourfold) shift to the left if lesioned animals, indicating behavioural supersensitivity. In contrast, L-DOPA-induced dyskinesias were only observed in MPTP-treated monkeys. Doses required for induction of dyskinesias were lower than those required to induce climbing. These findings provide further evidence that nigrostriatal damage is essential for the genesis of L-DOPA-induced dykinesias.
引用
收藏
页码:448 / 458
页数:11
相关论文
共 26 条
[1]  
[Anonymous], 1982, MOVEMENT DISORD
[2]   A SURVEY OF DRUG-INDUCED EXTRAPYRAMIDAL REACTIONS [J].
AYD, FJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 175 (12) :1054-&
[3]   PERMANENT HUMAN PARKINSONISM DUE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) - 7 CASES [J].
BALLARD, PA ;
TETRUD, JW ;
LANGSTON, JW .
NEUROLOGY, 1985, 35 (07) :949-956
[4]   RATIONALE FOR USE OF L-DOPA IN TORSION DYSTONIAS [J].
BARBEAU, A .
NEUROLOGY, 1970, 20 (11) :96-+
[5]  
BARNES N J G, 1986, British Journal of Pharmacology, V88, p304P
[6]   DOES LEVODOPA AGGRAVATE PARKINSONS-DISEASE [J].
BLIN, J ;
BONNET, AM ;
AGID, Y .
NEUROLOGY, 1988, 38 (09) :1410-1416
[7]  
CLARKE CE, 1987, LANCET, V1, P625
[8]  
CLARKE CE, 1988, N-S ARCH PHARMACOL, V338, P35
[9]  
CRISWELL H, 1989, J NEUROSCI, V9, P125
[10]   RELATIONSHIP BETWEEN TARDIVE-DYSKINESIA, L-DOPA-INDUCED HYPERKINESIA AND PARKINSONISM [J].
GERLACH, J .
PSYCHOPHARMACOLOGY, 1977, 51 (03) :259-263